{"product_id":"liposomal-vitamin-d3-b2b-ingredient","title":"Liposomal Vitamin D3 - B2B Ingredient","description":"\u003cp\u003e\u003cstrong\u003eLiposomal vitamin D3 concept for low-dose liquid or dry formulations.\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eSingle-ingredient phospholipid-delivery vitamin D3 concept for liquid or dry formats, designed for low-dose distribution and formulation flexibility.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eModel Number:\u003c\/strong\u003e LIP-06\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRelease Profile:\u003c\/strong\u003e Immediate\/non-modified release\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition:\u003c\/strong\u003e Vitamin D3 in a phospholipid delivery system (composition TBD)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnit of Measure:\u003c\/strong\u003e kg\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cem\u003eTechnical \u0026amp; regulatory notes: Secondary product. Confirm potency uniformity, protection during shelf life, supplied-state particle size, and reconstituted particle size where a dry format is developed. Immediate\/non-modified-release scope. Commercial release requires active identity and assay, phospholipid composition and active-to-phospholipid ratio, particle size and PDI, free versus associated active, morphology, stability, and a product-specific EU novel-food\/engineered-nanomaterial assessment. Source: NexaGens_Liposomal_Ingredient_Portfolio(2).docx.\u003c\/em\u003e\u003c\/p\u003e","brand":"NexaGens","offers":[{"title":"Default Title","offer_id":58506031006044,"sku":"NG-LIP-VITD3","price":0.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1040\/9223\/8172\/files\/nexagens-placeholder_624aab41-3cb2-493d-83c0-e9d9f563431a.png?v=1785519795","url":"https:\/\/nexagens.com\/products\/liposomal-vitamin-d3-b2b-ingredient","provider":"Nexagens","version":"1.0","type":"link"}